Clinical Trials Sponsored by CStone Pharmaceuticals

Total 20034 results

Novartis Pharmaceuticals
Ono Pharmaceutical Co. Ltd

Completed

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Alzheimer's Disease

Japan
Holy Stone Healthcare Co., Ltd

Not yet recruiting

Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
Holy Stone Healthcare Co., Ltd

Temporarily not available

Individual Patient Expanded Access to CA102N

Advanced or Metastatic Colorectal Cancer (mCRC)
Holy Stone Healthcare Co., Ltd

Completed

Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers (IBD98-M)

Healthy

Canada
Lee's Pharmaceutical Limited
Powder (Guangzhou) Pharmaceuticals Limited; Powder Pharmaceuticals (HK) Co....

Not yet recruiting

A Study of the Continuous Glucose Monitoring System for Home Use in Patients With Diabetes

Diabetes
Tracon Pharmaceuticals Inc.
Janssen Pharmaceutica N.V., Belgium

Completed

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Metastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, Prostate

United States
Kissei Pharmaceutical Co., Ltd.
JCR Pharmaceuticals Co., Ltd.

Completed

A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

Anemia

Japan
Tasly Pharmaceuticals, Inc.
Tasly Pharmaceutical Group Co., Ltd

No longer available

Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19

Covid19

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States, Spain, Canada, Australia, United Kingdom, Germany, Netherlands, Belgium, Austria, France
Kissei Pharmaceutical Co., Ltd.
JCR Pharmaceuticals Co., Ltd.

Completed

A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

Anemia

Japan
Aston University

Not yet recruiting

Photobiomodulation With REd vs BluE Light (REBEL)

Dry Eye Syndromes | Meibomian Gland Dysfunction | Blepharitis

United Kingdom
Aston University

Suspended

Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

Canada
Aston University

Completed

Dry Eye Treatment With Artificial Tears

Dry Eye

United Kingdom
Aston University

Completed

EyeBag Effectiveness in Meibomian Gland Dysfunction (MGD)

Meibomian Gland Dysfunction

United Kingdom
Aston University

Not yet recruiting

Protecting the Eyes of Gamers With Lubricating Eyedrops (PROTEGE)

Dry Eye Syndromes | Computer Vision Syndrome
Aston University

Recruiting

Mechanisms of Light-based Therapies for Dry Eye Disease (MOLT)

Dry Eye Syndromes | Meibomian Gland Dysfunction

United Kingdom
Aston University

Recruiting

Assessing the Impact of Tixel Treatment of Periorbital Wrinkles on Dry Eye Symptoms and Signs

Dry Eye | Dry Eye Syndromes

United Kingdom
Aston University

Enrolling by invitation

Assessment of Visual Function and Optics in Intraocular Lenses

Cataract

United Kingdom
Aston University

Completed

Using Models' Facial Expressions to Enhance Healthy Eating Behaviour in Children

Eating Behavior

United Kingdom
Aston University

Completed

Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments.

Ocular Hypertension | Glaucoma | Keratoconus | Glaucoma, Open Angle

United Kingdom
Austin V Stone

Not yet recruiting

Enhancing Recovery Through a Combined Mechanobiologic Intervention Following Meniscus Repair

Meniscus Lesion | Meniscus Tear | Meniscus Disorder | Meniscus; Derangement

United States
Austin V Stone

Terminated

PROPER Trial of Pain and Inflammation After Knee Arthroscopy (PROPER)

Cartilage Injury | Meniscus Lesion | Meniscus Tear

United States
Austin V Stone

Terminated

Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury (SLAM)

Anterior Cruciate Ligament Tear | Tibial Meniscus Injuries | Tibial Meniscus Tears | Tibial Meniscus, Torn

United States
University of Rochester
Mae Stone Goode Foundation

Completed

Novel Topical Therapies for the Treatment of Genital Pain (Topicals)

Female Genital Diseases

United States
Jina Pharmaceuticals Inc.
Novum Pharmaceutical Research Services; Lambda Therapeutic Research Ltd.; Intas...

Recruiting

Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Bipolar I Disorder

United States
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

Belgium
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients (EVOLUTION)

Multiple Myeloma

United States
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma

Multiple Myeloma

Austria
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma

Multiple Myeloma

Belgium, France, Germany
Johnson & Johnson Pharmaceutical Research & Development...
Peninsula Pharmaceuticals, Inc.

Completed

Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis

Urinary Tract Infections | Pyelonephritis
Johnson & Johnson Pharmaceutical Research & Development...
ALZA; Sequus Pharmaceuticals

Terminated

CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Ovarian Neoplasms
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma

Multiple Myeloma

United States
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

Non-Small Cell Lung Cancer

Belgium
Stony Brook University

Recruiting

Impact of Art Therapy on Self-Reported Pain and Anxiety Scores of Patients Waiting to Be Seen in the Emergency Department

Pain | Anxiety

United States
Stony Brook University

Recruiting

Treatment of Non-Anemic Iron Deficiency in Pregnancy

Non-anemic Iron Deficiency

United States
Stony Brook University

Recruiting

Dexamethasone to Target Stress and Immune System Mechanisms Underlying Alcohol Craving

Alcohol Use Disorder

United States
Aston Sci. Inc.

Recruiting

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer (Cornerstone001)

Breast Cancer

United States, Taiwan
Stony Brook University

Recruiting

Harnessing Network Science to Personalize Scalable Interventions for Adolescent Depression (TRACK to TREAT Phase 2)

Depression

United States
Stoke Therapeutics, Inc

Enrolling by invitation

An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome

Dravet Syndrome

United States
Stony Brook University

Completed

TENS for Back Pain Emergency Department

Back Pain

United States
Stony Brook University

Completed

Neuroprotection in Acute Ischemic Stroke (H2M)

Stroke, Ischemic

United States
Stony Brook University

Active, not recruiting

Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery (SBRT BREAST)

Breast Cancer

United States
Stony Brook University

Completed

NSAID Effects on Clinical and Imaging Breast Biomarkers

Pain | Inflammation | Hypertension | Cancer

United States
Stony Brook University

Active, not recruiting

A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies

Parkinson Disease | Multiple System Atrophy | Normal Pressure Hydrocephalus | Rapid Eye Movement Sleep Behavior Disorder

United States
Stony Brook University

Active, not recruiting

Lifestyle Intervention to Reduce Body Weight and Systemic Inflammation Among World Trade Center Responders

Inflammation | Metabolic Syndrome | Overweight and Obesity | Post-Traumatic Stress Disorder

United States
Stony Brook University

Completed

Evaluating the Single-Session Consultation Service at the Krasner Psychological Center and Putnam (SSC@KPC&Putnam)

Mental Health Impairment

United States
Stony Brook University

Unknown

Improving Outcomes in Cardiac Arrest With Inhaled Nitric Oxide

Cardiac Arrest

United States
Stony Brook University

Withdrawn

Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder)

Adhesive Capsulitis | Frozen Shoulder

United States
Stony Brook University

Completed

Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS (MSCycling)

Multiple Sclerosis

United States
Stony Brook University

Unknown

Evaluating the Efficacy of ABC for High-Risk Parent and Infants

Attachment Disorders

United States

Clinical Trials Sponsored by CStone Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations